The following is management's discussion and analysis of certain significant
factors that have affected our financial position and operating results during
the periods included in the accompanying unaudited condensed consolidated
financial statements.



OVERVIEW



Nano Magic develops, commercializes and markets cutting-edge consumer and
industrial products powered by nanotechnology to clean, protect and enhance
every-day surfaces. Our primary business is the formulation, marketing and sale
of products powered by nanotechnology bearing the Nano Magic brand as well as
Ultra Clarity and Defog It brand names and we also private label our solutions,
such as our eyeglass cleaner, our defogging products and nanocoating products
for glass and ceramics. We have historically sold our consumer products directly
to opticians and ophthalmologists and small optical retailers and we will
continue to do so, even as we are now working to expand product portfolio and
our consumer sales through big box retailers and e-commerce.



Effective May 31, 2022, we sold a majority interest in our subsidiary, Applied
Nanotech, Inc. ("ANI"). ANI performs contract research services for the Company
and for governmental and private customers and that work was previously reported
as our Contract research segment. We retain a 30% interest in ANI that is now
recorded as an equity investment.



RESULTS OF OPERATIONS



The following comparative analysis on results of operations was based primarily
on the comparative condensed consolidated financial statements, footnotes and
related information for the periods identified below and should be read in
conjunction with the unaudited condensed consolidated financial statements and
the notes to those statements that are included elsewhere in this report. The
results discussed below are for the three and nine months ended September 30,
2022 and 2021.


Comparison of Results of Continuing Operations for the Three and Nine Months ended September 30, 2022 and 2021





Revenues:


For the three and nine months ended September 30, 2022 and 2021, revenues from continuing operations were:





                  Three Months Ended             Nine Months Ended
                     September 30,                 September 30,
                  2022          2021           2022            2021
Total revenue   $ 807,026     $ 545,515     $ 1,819,951     $ 3,673,263




For the three months ended September 30, 2022, sales from continuing operations
increased by $261,511 or 48% as compared to the three months ended September 30,
2021. For the nine months ended September 30, 2022 revenues decreased by
$1,853,312 or 50%, as compared to the nine months ended September 30, 2021. The
increase for the three-month period was due primarily to growth in the company's
e-commerce sales channel. The decrease for the nine-month period was primarily
due to the high sales of anti-fog products during the first half of 2021 when
masks were required in many situations due to the COVID-19 pandemic.



Cost of sales



Cost of sales includes inventory costs, materials and supplies costs, internal
labor and related benefits, subcontractor costs, depreciation, and overhead and
shipping and handling costs incurred.



                   Three Months ended             Nine Months ended
                      September 30,                 September 30,
                   2022          2021           2022            2021
Cost of sales:   $ 698,448     $ 525,892     $ 1,689,342     $ 2,109,430




For the three months ended September 30, 2022, cost of revenues increased by
$172,556 or 33% as compared to the three months ended September 30, 2021. For
the nine months ended September 30, 2022, cost of revenues decreased by $420,088
or 20% as compared to the nine months ended September 30, 2021. For the
three-month period, the increase reflects the higher sales volume as compared to
the prior year. For the nine-month period, cost of sales decreased as sales
volume dropped, but did not reduce proportionately because of overhead and other
fixed production costs. We saw some price increases and shortages for some of
our raw materials and packaging during the COVID-19 pandemic and the ongoing
supply chain disruption, but thus far we have been able to obtain adequate

supply.



Gross profit and gross margin



For the three months ended September 30, 2022, gross profit was $108,578 as
compared to $19,623 for the prior year, an increase of $88,955 or 453%. For the
nine months ended September 30, 2022, gross profit was $130,609 as compared to
$1,563,833 for the prior year, a decrease of $1,433,224 or 92%. For the nine
months ended September 30, 2022, gross margin was 7.2% as compared to 42.6% in
the prior year. For the three months ended September 30, 2022, gross margin was
13.5% as compared to 3.6% in the prior year. For the three-month period the
improvement was due to a combination of higher sales volume and lower fixed
overhead costs at the plant. For the nine-month period the decrease was due to
lower sales volumes as well as product mix.



4







Other operating income



For the three months ended September 30, 2022, other operating income increased
by $44,129 or 86% compared to the three months ended September 30, 2021. This
was due primarily to settlement income from a customer in the third quarter of
2022. For the nine months ended September 30, 2022, other operating income
decreased by $456,408 or 83% compared to the nine months ended September 30,
2021. This was due primarily to settlement income from a third party received in
the first half of 2021 that significantly decreased in subsequent periods.




Operating expenses



For the three months ended September 30, 2022, operating expenses decreased by
$104,924 or 12% compared to the three months ended September 30, 2021.
Similarly, for the nine months period operating expenses decreased by $418,063
or 14% for the period ended September 30, 2022, as compared to the nine months
ended September 30, 2021. For the three and nine months ended September 30, 2022
and 2021, operating expenses consisted of the following:



                                          Three Months Ended              Nine Months Ended
                                             September 30,                  September 30,
                                          2022           2021           2022            2021
Selling and marketing expenses         $   88,635     $   59,203     $   264,465     $   136,423
Salaries, wages and related benefits      359,273        464,042       1,178,612       1,754,585
Research and development                    4,566          2,482          15,266          11,795
Professional fees                         129,362        183,167         572,135         592,067
General and administrative expenses       183,728        161,594         646,989         600,660
Total                                  $  765,564     $  870,488     $ 2,677,467     $ 3,095,530

? For the three months ended September 30, 2022, selling and marketing expenses

increased by $29,432 or 50% as compared to the three months ended September 30,

2021, due to increased marketing expenses, sales consultants and trade show

expenses. For the nine months ended September 30, 2022, selling and marketing

expenses increased by $128,042 or 94% as compared to the nine months ended

September 30, 2021, due to the foregoing factors.

? For the three months ended September 30, 2022, salaries, wages and related

benefits decreased by $104,769 or 23%, as compared to the three months ended

September 30, 2021. For the nine months ended September 30, 2022, salaries,

wages and related benefits decreased by $575,973 or 33%, as compared to the

nine-months ended September 30, 2021. These decreases were due to lower bonus

and equity compensation expenses, and reduced staffing in light of lower sales


  volumes.




? For the three months ended September 30, 2022, research and development costs

increased by $2,084 or 84%, as compared to the three months ended September 30,

2021. For the nine months ended September 30, 2022, research and development

costs increased by $3,471 or 29%, as compared to the nine months ended

September 30, 2021. The changes were due to the timing of expenses in the

course of ongoing work.

? For the three months ended September 30, 2022, professional fees decreased by

$53,805 or 29%, as compared to the three months ended September 30, 2021. For

the nine months ended September 30, 2022, professional fees decreased by

$19,932 or 3%, as compared to the nine months ended September 30, 2021. The

changes were due to ongoing legal expenses related to our challenge to the SEC

trading suspension and additional trademark expenses in 2022 that decreased in

comparison to prior periods in 2021.

? For the three months ended September 30, 2022, general and administrative

expenses increased by $22,134 or 14% as compared to the three months ended

September 30, 2021. For the nine months ended September 30, 2022, general and

administrative expenses increased by $46,329 or 8% as compared to the nine

months ended September 30, 2021. In both comparative periods costs increased


  primarily due to increased board and governance costs.




Loss from operations



As a result of the factors described above, for the three months ended September
30, 2022, loss from operations amounted to $561,285 as compared to a loss of
$799,293 for the three months ended September 30, 2021, a change of $238,008 or
30%. For the nine-month period ended September 30,2022, the loss was $2,451,157,
as compared to a loss of $979,588 for the nine months ended September 30, 2021,
an increase of $1,471,569 or 150%.



5






Income from investment in subsidiary





As a result of the sale of a 70% interest in ANI , we now report our 30% share
of ANI's income or loss as an investment in a subsidiary. For the three months
ended September 30, 2022 that was income of $19,203, and for the nine months
then ended income of $16,042.



Interest expense



For the three months ended September 30, 2022 interest expense was $10,799 as
compared to $3,879 in the prior year, and for the nine months ended September
30, 2022 interest expense was $26,414 up from $13,874 in the prior year. The
increases were due to interest expense for convertible notes issued in 2022.



Other income



For the three months ended September 30, 2022, other income was $10,267 as
compared to $0 for the three months ended September 30, 2021. For the nine
months ended September 30, 2022, other income was $12,892 as compared to $10 for
the nine months ended September 30, 2021. The increases were due to interest
income accrued on notes receivable issued in 2022.



Loss from continuing operations


As a result of the foregoing, we reported a loss from continuing operations of
$542,594 for the three-month period ended September 30, 2022 and a loss of
$803,172 for the three-month period in the prior year, a decrease of $260,578 or
32%. For the nine-month period ended September 30, 2022 our loss from continuing
operations was $2,448,637 as compared to $993,452 for the nine-month period
ended September 30, 2021, an increase of $1,455,185 or 146%.



Income (loss) from discontinued operations


Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of
its officers and long-time employees in exchange for a promissory note in the
face amount of $450,000. We recognized no income on that discontinued operation
for the three-month period ended September 30, 2022 and on a comparative basis
we recognized income of $45,603 for the three-month period ended September 30,
2021. For the nine months ended September 30, 2022 we had income from
discontinued operations of $1,300 and income of $132,863 on a comparative basis
for the three-month period ended September 30, 2021. For the nine months ended
September 30, 2022, we reported a gain on sale of discontinued operations of
$1,148,225 and $0 on a comparative basis for the nine-month period ended
September 30, 2021.



Net loss (income)



For the three months ended September 30, 2022, net loss was $542,594 as compared
to a net loss of $757,569 for the three months ended September 30, 2021. For the
nine months ended September 30, 2022, net loss amounted to $1,299,112 as
compared to a loss of $860,769 for the nine months ended September 30, 2021.



LIQUIDITY AND CAPITAL RESOURCES





Liquidity is the ability of an enterprise to generate adequate amounts of cash
to meet its needs for cash requirements. We had working capital of $942,354 and
$206,286 of unrestricted cash as of September 30, 2022 and working capital of
$1,003,127 and $197,932 of unrestricted cash as of December 31, 2021.



The following table sets forth a summary of changes in our working capital from December 31, 2021 to September 30, 2022:





                                                                          December 31, 2021 to
                                                                           September 30, 2022
                                                                      Change in
                                    September       December 31,       Working          Percentage
                                     30, 2022           2021           Capital            Change
Working capital:
Total current assets               $  2,094,940     $  2,156,666     $    (61,726 )           (2.86 )%
Total current liabilities             1,152,586        1,153,539             (953 )           (0.08 )%
Working capital:                   $    942,354     $  1,003,127     $    (60,773 )           (6.06 )%




6






The decrease in current assets is primarily attributable to a decrease in inventory and prepaid expenses partially offset by an increase in accounts receivable.


Net cash used by operating activities was $(1,561,063) for the nine months ended
September 30, 2022 as compared to net cash used by operating activities of
$(641,196) for the nine months ended September 30, 2021, a net change of
$(919,867) or 143%. Net cash used by operating activities for the nine months
ended September 30, 2022 primarily resulted from net loss from continuing
operations of $(2,448,637) adjusted for add-backs of $240,421 and changes in
operating assets and liabilities of $719,398.



Net cash provided by continuing investing activities was $20,090 for the nine
months ended September 30, 2022, as compared to net cash used by continuing
investing activities of $(104,585) for the same period in 2021. Net cash used by
discontinued investing activities was $0 and $(242) for the nine months ended
September 30, 2022 and September 30, 2021, respectively.



Net cash provided by continuing financing activities was $1,484,785 for the nine
months ended September 30, 2022 reflecting $1,610,000 in proceeds from sales of
common stock, warrants and convertible notes, as compared to net cash provided
by continuing financing activities of $1,396,555 for the same period in 2021.
Net cash provided by discontinued financing activities was $20,000 and $76,305
for the nine months ended September 30, 2022 and September 30, 2021,
respectively.



Future Liquidity and Capital Needs.





Our principal future uses of cash are for working capital requirements,
including working capital to support increased product sales, sales and
marketing expenses and reduction of accrued liabilities. Application of funds
among these uses will depend on numerous factors including our sales and other
revenues and our ability to control costs.



Equipment Financing and Loans


See note 6 to our unaudited condensed consolidated financial statements regarding our equipment loan and financing leases.

Off-Balance Sheet Arrangements





We have not entered into any other financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to our shares and classified as
shareholder's equity or that are not reflected in our consolidated unaudited
financial statements. Furthermore, we do not have any retained or contingent
interest in assets transferred to an unconsolidated entity that serves as
credit, liquidity or market risk support to such entity. We do not have any
variable interest in any unconsolidated entity that provides financing,
liquidity, market risk or credit support to us or engages in leasing, hedging or
research and development services with us.

© Edgar Online, source Glimpses